Company Overview

Update
Headquarters:
New York, NY
IPO:
Went Public on May 23, 2003
Stock:
OTCMKTS:ALQAD
Categories:
Biotechnology

Alliquais a biomedical company that develops, manufactures and markets its proprietary products by utilizing a technology portfolio.

Description

Update

Headquartered in New York, Alliqua, Inc., (OTCBB:ALQA) is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products, utilizing its existing technology portfolio. The company currently markets its own proprietary brands of wound dressings: SilverSeal® Hydrogel, an antimicrobial dressing; and Hydress® a moist wound dressing. We intend to pursue projects in the fields of active ingredient and transdermal drug delivery, as well as advanced wound care.

Alliqua’s core transdermal delivery technology platform is designed to deliver drugs and other beneficial ingredients through the skin. Transdermal delivery has multiple advantages over conventional oral and injection delivery including: Avoidance of hepatic first pass metabolism causing less stress on the liver; Non-invasive nature; Improved patient compliance; Discontinuation of administration by removal of the system; Lower... See More

Current Team (13)

Update

Board Members and Advisors (8)

Update

Funding Rounds (7) - $40.80M

Update
  • $1M

    Investors Unknown
    Nov 6, 2013 -Unknown
  • $3M

    Investors Unknown
    Jul 7, 2013 -Unknown
  • $815k

    Investors Unknown
    Nov 16, 2012 -Unknown
  • $1.10M

    Investors Unknown
    Mar 1, 2012 -Unknown

Offices/Locations (1)

Update
  • Office

    850 THIRD AVENUE

    SUITE 1801

    New York, NY 10022

    USA

Images (1)

Update
  • 5e940aa7662e676e5e72e7ef693eb100